Skip to main content
Top
Published in: Pediatric Cardiology 6/2016

01-08-2016 | Original Article

Respiratory Tract Infection and Risk of Hospitalization in Children with Congenital Heart Defects During Season and Off-Season: A Swedish National Study

Authors: Elin Granbom, Eva Fernlund, Jan Sunnegårdh, Bo Lundell, Estelle Naumburg

Published in: Pediatric Cardiology | Issue 6/2016

Login to get access

Abstract

Respiratory tract infections (RTI) are common among young children, and congenital heart defect (CHD) is a risk factor for severe illness and hospitalization. This study aims to assess the relative risk of hospitalization due to RTI in winter and summer seasons for different types of CHD. All children born in Sweden and under the age of two, in 2006–2011, were included. Heart defects were grouped according to type. Hospitalization rates for respiratory syncytial virus (RSV) infection and RTI in general were retrieved from the national inpatient registry. The relative risk of hospitalization was calculated by comparing each subgroup to other types of CHD and otherwise healthy children. The relative risk of hospitalization was increased for all CHD subgroups, and there was a greater increase in risk in summer for the most severe CHD. This included RSV infection, as well as RTI in general. The risk of hospitalization due to RTI is greater for CHD children. Prophylactic treatment with palivizumab, given to prevent severe RSV illness, is only recommended during winter. We argue that information to healthcare staff and parents should include how the risk of severe infectious respiratory tract illnesses, RSV and others, is present all year round for children with CHD.
Literature
1.
go back to reference Eggleston HA, Gunville CF, Miller JI, Sontag MK, Mourani PM (2013) A comparison of characteristics and outcomes in severe human metapneumovirus and respiratory syncytial virus infections in children treated in an intensive care unit. Pediatr Infect Dis J. doi:10.1097/INF.0b013e3182a2261b PubMed Eggleston HA, Gunville CF, Miller JI, Sontag MK, Mourani PM (2013) A comparison of characteristics and outcomes in severe human metapneumovirus and respiratory syncytial virus infections in children treated in an intensive care unit. Pediatr Infect Dis J. doi:10.​1097/​INF.​0b013e3182a2261b​ PubMed
3.
go back to reference Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B, New Vaccine Surveillance N (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113(6):1758–1764CrossRefPubMed Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B, New Vaccine Surveillance N (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113(6):1758–1764CrossRefPubMed
4.
go back to reference Falkenstein-Hagander K, Mansson AS, Redmo J, Nilsson Wimar P, Widell A (2014) Viral aetiology and clinical outcomes in hospitalised infants presenting with respiratory distress. Acta Paediatr 103(6):625–629. doi:10.1111/apa.12623 CrossRefPubMed Falkenstein-Hagander K, Mansson AS, Redmo J, Nilsson Wimar P, Widell A (2014) Viral aetiology and clinical outcomes in hospitalised infants presenting with respiratory distress. Acta Paediatr 103(6):625–629. doi:10.​1111/​apa.​12623 CrossRefPubMed
5.
go back to reference Bosis S, Esposito S, Niesters HG, Zuccotti GV, Marseglia G, Lanari M, Zuin G, Pelucchi C, Osterhaus AD, Principi N (2008) Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences. Clin Microbiol Infect 14(7):677–684. doi:10.1111/j.1469-0691.2008.02016.x CrossRefPubMed Bosis S, Esposito S, Niesters HG, Zuccotti GV, Marseglia G, Lanari M, Zuin G, Pelucchi C, Osterhaus AD, Principi N (2008) Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences. Clin Microbiol Infect 14(7):677–684. doi:10.​1111/​j.​1469-0691.​2008.​02016.​x CrossRefPubMed
7.
go back to reference Kristensen K, Stensballe LG, Bjerre J, Roth D, Fisker N, Kongstad T, Svendsen AL, Nielsen BW (2009) Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch Dis Child 94(10):785–789. doi:10.1136/adc.2008.143057 CrossRefPubMed Kristensen K, Stensballe LG, Bjerre J, Roth D, Fisker N, Kongstad T, Svendsen AL, Nielsen BW (2009) Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch Dis Child 94(10):785–789. doi:10.​1136/​adc.​2008.​143057 CrossRefPubMed
8.
go back to reference Alexander PM, Eastaugh L, Royle J, Daley AJ, Shekerdemian LS, Penny DJ (2012) Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease. J Paediatr Child Health 48(5):395–401CrossRefPubMed Alexander PM, Eastaugh L, Royle J, Daley AJ, Shekerdemian LS, Penny DJ (2012) Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease. J Paediatr Child Health 48(5):395–401CrossRefPubMed
10.
11.
go back to reference Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr, Connor EM, Sondheimer HM, Cardiac Synagis Study G (2003) Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 143(4):532–540CrossRefPubMed Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr, Connor EM, Sondheimer HM, Cardiac Synagis Study G (2003) Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 143(4):532–540CrossRefPubMed
12.
13.
go back to reference Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Murguia De Sierra T, Simoes EA, Shaha S, Welliver R (2007) The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect 135(7):1077–1090. doi:10.1017/S095026880600776X CrossRefPubMedPubMedCentral Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Murguia De Sierra T, Simoes EA, Shaha S, Welliver R (2007) The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect 135(7):1077–1090. doi:10.​1017/​S095026880600776​X CrossRefPubMedPubMedCentral
14.
go back to reference Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW (1998) Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 121(1):121–128CrossRefPubMedPubMedCentral Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW (1998) Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 121(1):121–128CrossRefPubMedPubMedCentral
15.
go back to reference Lapena S, Robles MB, Castanon L, Martinez JP, Reguero S, Alonso MP, Fernandez I (2005) Climatic factors and lower respiratory tract infection due to respiratory syncytial virus in hospitalised infants in northern Spain. Eur J Epidemiol 20(3):271–276CrossRefPubMed Lapena S, Robles MB, Castanon L, Martinez JP, Reguero S, Alonso MP, Fernandez I (2005) Climatic factors and lower respiratory tract infection due to respiratory syncytial virus in hospitalised infants in northern Spain. Eur J Epidemiol 20(3):271–276CrossRefPubMed
20.
go back to reference Svensson C, Berg K, Sigurs N, Trollfors B (2015) Incidence, risk factors and hospital burden in children under five years of age hospitalised with respiratory syncytial virus infections. Acta Paediatr 104(9):922–926. doi:10.1111/apa.13061 CrossRefPubMed Svensson C, Berg K, Sigurs N, Trollfors B (2015) Incidence, risk factors and hospital burden in children under five years of age hospitalised with respiratory syncytial virus infections. Acta Paediatr 104(9):922–926. doi:10.​1111/​apa.​13061 CrossRefPubMed
21.
go back to reference Parnes C, Guillermin J, Habersang R, Nicholes P, Chawla V, Kelly T, Fishbein J, McRae P, Goessler M, Gatti A, Calcagno JA, Eki C, Harris KA, Joyave J, McFarland K, Protter P, Sullivan M, Stanford A, Lovett N, Ortiz M, Rojas S, Cyrus S, Cyrus J, Cohen S, Buchin D, Riordan L, Zuniga M, Shah R, Minard C, Quintin A, Douglas G, van Houten J, Freutner S, Chartrand S, Nowatzke P, Romero J, Rhodes T, Benoit M, Walter E, Walker L, DeBonnett L, Cross M, Free T, Martin S, Shank K, Guedes B, Atkinson LA, Halpin GJ, Rouse K, Hand I, Geiss D, Marshall JR, Burleson L, Boland J, Seybold K, Hunter V, Unfer S, Schmucker J, Gley M, Marcus M, Thompson P, Milla P, Young C, Zanni R, Zinno V, Fetter-Zarzeka A, Busey A, Sokunbi MA, Airington S, Richard N, Muraligopal V, Lewis S, Weber FT, Giordano BP, Linehan D, Roach J, Davis R, Rzepka AA, Booth T, Smeltzer D, Walsh J, Arispe E, Rowley R, Bolling C, Botts T, Haskett K, Raby D, Batiz E, Gelfand A, Farrell L, Butler S, Colby L, Schochet P, Bentler J, Hirsch D, Wilkinson L, Aaronson A, Bennett E, Wingate J, Quinn D, Komendowski K, Deckard M, Frogel M, Nerwen C, Copenhaver S, Prater M, Wolsztein J, Mackey K, Benbow M, Naranjo M, Hensley S, Hayes C, Sadeghi H, Lawson SM, McCall M, Combs K, Ledbetter J, Sarnosky K, Swafford C, Speer M, Barton WJ, Mink JW, Lemm D, Hudak M, Case E, Rowen J, Fuentes S, Pane C, Richardson L, Chavarria C, Cassino D, Ghaffari K, Carroll C, Lee H, Guclu L, Johnson C, Blum V, Boron ML, Sorrentino M, Hirsch RL, Van Veldhuisen PC, Smith C, Palivizumab Outcomes Registry Study G (2003) Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: results from The Palivizumab Outcomes Registry. Pediatr Pulmonol 35(6):484–489. doi:10.1002/ppul.10288 CrossRefPubMed Parnes C, Guillermin J, Habersang R, Nicholes P, Chawla V, Kelly T, Fishbein J, McRae P, Goessler M, Gatti A, Calcagno JA, Eki C, Harris KA, Joyave J, McFarland K, Protter P, Sullivan M, Stanford A, Lovett N, Ortiz M, Rojas S, Cyrus S, Cyrus J, Cohen S, Buchin D, Riordan L, Zuniga M, Shah R, Minard C, Quintin A, Douglas G, van Houten J, Freutner S, Chartrand S, Nowatzke P, Romero J, Rhodes T, Benoit M, Walter E, Walker L, DeBonnett L, Cross M, Free T, Martin S, Shank K, Guedes B, Atkinson LA, Halpin GJ, Rouse K, Hand I, Geiss D, Marshall JR, Burleson L, Boland J, Seybold K, Hunter V, Unfer S, Schmucker J, Gley M, Marcus M, Thompson P, Milla P, Young C, Zanni R, Zinno V, Fetter-Zarzeka A, Busey A, Sokunbi MA, Airington S, Richard N, Muraligopal V, Lewis S, Weber FT, Giordano BP, Linehan D, Roach J, Davis R, Rzepka AA, Booth T, Smeltzer D, Walsh J, Arispe E, Rowley R, Bolling C, Botts T, Haskett K, Raby D, Batiz E, Gelfand A, Farrell L, Butler S, Colby L, Schochet P, Bentler J, Hirsch D, Wilkinson L, Aaronson A, Bennett E, Wingate J, Quinn D, Komendowski K, Deckard M, Frogel M, Nerwen C, Copenhaver S, Prater M, Wolsztein J, Mackey K, Benbow M, Naranjo M, Hensley S, Hayes C, Sadeghi H, Lawson SM, McCall M, Combs K, Ledbetter J, Sarnosky K, Swafford C, Speer M, Barton WJ, Mink JW, Lemm D, Hudak M, Case E, Rowen J, Fuentes S, Pane C, Richardson L, Chavarria C, Cassino D, Ghaffari K, Carroll C, Lee H, Guclu L, Johnson C, Blum V, Boron ML, Sorrentino M, Hirsch RL, Van Veldhuisen PC, Smith C, Palivizumab Outcomes Registry Study G (2003) Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: results from The Palivizumab Outcomes Registry. Pediatr Pulmonol 35(6):484–489. doi:10.​1002/​ppul.​10288 CrossRefPubMed
22.
go back to reference Granbom E, Fernlund E, Sunnegardh J, Lundell B, Naumburg E (2014) Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease. Acta Paediatr 103(8):840–845. doi:10.1111/apa.12658 CrossRefPubMed Granbom E, Fernlund E, Sunnegardh J, Lundell B, Naumburg E (2014) Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease. Acta Paediatr 103(8):840–845. doi:10.​1111/​apa.​12658 CrossRefPubMed
23.
go back to reference American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134(2):415–420. doi:10.1542/peds.2014-1665 CrossRef American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134(2):415–420. doi:10.​1542/​peds.​2014-1665 CrossRef
27.
Metadata
Title
Respiratory Tract Infection and Risk of Hospitalization in Children with Congenital Heart Defects During Season and Off-Season: A Swedish National Study
Authors
Elin Granbom
Eva Fernlund
Jan Sunnegårdh
Bo Lundell
Estelle Naumburg
Publication date
01-08-2016
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 6/2016
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-016-1397-4

Other articles of this Issue 6/2016

Pediatric Cardiology 6/2016 Go to the issue